Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare aggressive myeloid neoplasm which shows a high rate of central nervous system (CNS) recurrence and overall survival (OS) of <1 year. Despite this, screening for CNS involvement is not routinely performed at diagnosis and intrathecal (...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-Martín, Lourdes, Almeida, Julia, Pomares, Helena, González-Barca, Eva, Bravo, Pilar, Giménez, Teresa, Heras, Cecilia, Queizán, José-Antonio, Pérez-Ceballos, Elena, Martínez, Violeta, Alonso, Natalia, Calvo, Carlota, Álvarez, Rodolfo, Caballero, María Dolores, Orfao, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891111/
https://www.ncbi.nlm.nih.gov/pubmed/26840087
http://dx.doi.org/10.18632/oncotarget.7101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891111/
https://www.ncbi.nlm.nih.gov/pubmed/26840087
http://dx.doi.org/10.18632/oncotarget.7101

Ejemplares similares